MedPath

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Phase 3
Terminated
Conditions
Alzheimer Disease
Interventions
Drug: bapineuzumab
Drug: placebo
Registration Number
NCT00667810
Lead Sponsor
Pfizer
Brief Summary

This is a study to evaluate the efficacy and safety of multiple doses of bapineuzumab in patients with mild to moderate Alzheimer Disease. Patients will receive either bapineuzumab or placebo. Each patient's participation will last approximately 1.5 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
901
Inclusion Criteria
  • Diagnosis of probable Alzheimer Disease (AD), with Mini Mental State Examination (MMSE) score of 16-26, and brain magnetic resonance imaging (MRI) consistent with the diagnosis of AD
  • Concurrent use of cholinesterase inhibitor or memantine allowed, if stable
  • Caregiver will participate and be able to attend clinic visits with patient
Read More
Exclusion Criteria
  • Significant neurological disease other than AD
  • Major psychiatric disorder
  • Contraindication to undergo brain MRI [e.g., pacemaker, cerebrospinal fluid (CSF) shunt, or foreign metal objects in the body]
  • Women of childbearing potential
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bapineuzumab 0.5 mg/kgbapineuzumab-
Bapineuzumab 1.0 mg/kgbapineuzumab-
Placeboplacebo-
Primary Outcome Measures
NameTimeMethod
The Change From Baseline in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)/11 Total Score at Week 7878 weeks

The ADAS-Cog is a multi-item, objective measure of cognitive function. The scale evaluates memory, language, and praxis with items such as orientation, word recall, word recognition, object identification, comprehension, and the completion of simple tasks. Analysis of the ADAS-Cog for this study was based upon an 11 item score from the following items 1) word recall task, 2) naming objects and fingers, 3) following commands, 4) constructional praxis, 5) ideational praxis, 6) orientation, 7) word recognition, 8) remembering test instructions, 9) spoken language ability, 10) word finding difficulty in spontaneous speech, and 11) comprehension. This scale had to be administered by a trained and certified psychometric rater who did not have access to any information regarding adverse events experienced. The ADAS-Cog/11 ranged from 0 to 70 points, with higher scores indicating a greater degree of impairment. A negative change from baseline indicates a decrease in cognitive impairment.

The Change From Baseline in the Disability Assessment for Demential (DAD) Total Score at Week 7878 weeks

The DAD measures instrumental and basic activities of daily living in participants with Alzheimer's Disease (AD). The DAD is administered to the participants'caregiver in the form of an interview. This scale had to be administered by a trained and certified global rater who did not have access to any information regarding adverse events experienced by the participant. This scale assesses a participants' ability to initiate, plan, and perform activities related to hygiene, dressing, continence, eating, meal preparation, telephoning, going on an outing, finance and correspondence, medications, leisure, and housework. Each item can be scored as 1 = yes, 0 = no, non applicable = NA. A total score is obtained by adding the rating for each question and converting this total score out of 100. Higher scores indicate better function; a positive change from baseline indicates an improvement.

Secondary Outcome Measures
NameTimeMethod
Time to First Clinically Meaningful Deterioration on ADAS-Cog/11 Total Score (United States [US] Analysis Plan)78 weeks

The time to first clinically meaningful deterioration (for the US) was defined as the first time a participant experienced an increase (worsening) from baseline in ADAS-Cog/11 total score of \>=7.

Change From Baseline in Clinical Dementia Rating Sum of Boxes (CDR-SOB) Total Score at Week 7878 Weeks

The CDR-SOB is a global clinical staging instrument that sums 6 clinical ratings: 1) memory, 2) orientation, 3) judgment and problem solving, 4) involvement in community affairs, 5) home and hobbies, and 6) personal care based on the Clinical Dementia Rating Scale (CDR) interview. The CDR includes discussions with the participant and caregiver using a structured format. This scale had to be administered by a trained and certified global rater who did not have access to any information regarding adverse events experienced by the participant. CDR-SOB total score range is 0 (least impairment) to 18 (most impairment); a negative change from baseline indicates an improvement.

The Change From Baseline in Phospho-tau Levels in the Cerebrospinal Fluid (CSF) at Week 71.71 Weeks

Biomarkers CSF phospho-tau (p-tau) is an indicator of neuronal injury and neurodegeneration. An elevation in levels of tau, as well as specific p-tau species, is thought to be a marker for progressive cellular degeneration in AD. Accordingly, a reduction from baseline in levels of CSF tau in participants who received bapineuzumab compared with participants who received placebo may be indicative of a reduction in neuronal loss in participants treated with bapineuzumab.

Divergence of Effect on the ADAS-Cog/11 Total Scores From Week 39 to Week 7839 Weeks

The MMRM estimated slope (based on linear contrasts) of the differences between bapineuzumab and placebo for the ADAS-Cog/11 total scores from Week 39 to Week 78 was presented.

Time to First Clinically Meaningful Deterioration on DAD Total Score (US Analysis Plan)78 Weeks

The time to first clinically meaningful deterioration was defined as the first time a participant experienced a decrease (worsening)from baseline in DAD total score of \>=12.

Percentage of Participants With Worsening From Baseline in DAD Total Score at Week 78 (US Analysis Plan)78 weeks

Percentage of participants whose decrease (worsening) from baseline to Week 78 in DAD total score was \<12.

Change From Baseline in Dependence Scale Total Score at Week 7878 Weeks

The Dependence Scale (DS) is a 13-item, caregiver-rated instrument for determining the amount of support required by a participant with AD. The DS total score ranges from 0 to 15, with higher scores indicating more need for assistance. The DS was administered as an interview to the caregiver at scheduled study visits.

Time to Median Placebo Deterioration on DAD Total Score78 Weeks

The time to first median placebo deterioration (for the EU) was defined as the first time a participant experienced a decrease (worsening) in DAD total score greater than or equal to the median worsening at Week 78 in the placebo group.

Percentage of Participants With Worsening From Baseline in ADAS-Cog/11 Total Score at Week 78 (US Analysis Plan)78 Weeks

Percentage of participants whose increase (worsening) from baseline to Week 78 in ADAS-Cog/11 total score is \<7.

Percentage of Participants With Worsening From Baseline in DAD Total Score at Week 78 (European Union Analysis Plan)78 Weeks

Percentage of participants whose decrease (worsening) from baseline to Week 78 in DAD total score was at most 0, 6, 12 points.

The Change From Baseline in Brain Amyloid Burden at Week 71.71 Weeks

Brain amyloid burden as imaged by 11C-Pittsburgh compound B (PiB) positron emission tomography (PET). The latter is a semiquantitative measure of the extent of fibrillar amyloid in the brain. PIB PET measurements were made in cortical regions found to have the highest burden of fibrillar amyloid at autopsy in participants diagnosed as having Alzheimer's pathology, and also regions reported to have the highest average retention of PIB signal in previous PET studies enrolling participants with probable AD. This parameter reflects overall brain amyloid deposition as indexed by imaging. The change from baseline was measured as average standard uptake value ratio (SUVr) in prespecified regions of interest (ROI) assessed by PIB PET imaging in a subset of participants.

The Change From Baseline in Brain Volume at Week 7171 Weeks

Brain volume was examined in a subset of participants by Magnetic Resonance Imaging Brain Boundary Shift Integral (MRI BBSI). Cerebral atrophy correlates closely with the gradual cognitive decline in AD and can be visualized by MRI. The BBSI technique involves positional matching of serial 3-dimensional MRI brain images, such that brain MRI-image volumes were first registered and then subtracted from each other. Atrophy rates would generally be expected to be lower if the underlying disease was attenuated by effective treatment.

Divergence of Effect on the DAD Total Scores From Week 39 to Week 7839 weeks

The MMRM estimated slope (based on linear contrasts)of the differences between bapineuzumab and placebo for the DAD total scores from Week 39 to Week 78 was presented.

Time to Median Placebo Deterioration on ADAS-Cog/11 Total Score (European Union [EU] Analysis Plan)78 Weeks

The time to first median placebo deterioration (for the EU) was defined as the first time a subject experienced an increase from baseline (worsening) in ADAS Cog/11 total score greater than or equal to the median worsening observed at Week 78 in the placebo group. The Kaplan Meier estimate of the median time to first median placebo deterioration in ADAS Cog/11 total score was presented.

Percentage of Participants With Worsening From Baseline in ADAS-Cog/11 Total Score at Week 78 (European Union Analysis Plan)78 Weeks

Percentage of participants whose increase (worsening) in ADAS-Cog/11 total score from baseline to Week 78 was at most 0, 3, 7 points.

Trial Locations

Locations (331)

Clinical Trials, Inc.

🇺🇸

Little Rock, Arkansas, United States

Center for Healthy Aging

🇺🇸

Greenwich, Connecticut, United States

Chase Medical Research, LLC

🇺🇸

Waterbury, Connecticut, United States

Marty's Pharmacy

🇺🇸

Flowood, Mississippi, United States

Bendheim Cancer Center

🇺🇸

Greenwich, Connecticut, United States

Research Center for Clinical Studies, Inc.

🇺🇸

Norwalk, Connecticut, United States

Memory Enhancement Center of America, Inc.

🇺🇸

Eatontown, New Jersey, United States

James Gary Booker, MD, APMC

🇺🇸

Shreveport, Louisiana, United States

Lake Charles Clinical Trials

🇺🇸

Lake Charles, Louisiana, United States

Spectrum Home Solutions

🇺🇸

Great Falls, Montana, United States

CBH Health, LLC

🇺🇸

Rockville, Maryland, United States

Memory Enhancement Center of New Jersey, Inc.

🇺🇸

Toms River, New Jersey, United States

Psicomedica Research Group

🇨🇱

Santiago, Chile

Especialidades Medicas L&S

🇨🇱

Santiago, Chile

Cliniques Universitaires Saint-Luc

🇧🇪

Bruxelles, Belgium

Ita-Suomen Yliopisto

🇫🇮

Kuopio, Finland

Yachiyo Hospital

🇯🇵

Aichi, Japan

Shinozuka Hospital

🇯🇵

Gunma, Japan

National Hospital Organization Hiroshima-nishi Medical Ctr.

🇯🇵

Hiroshima, Japan

Nippon Medical School Musashikosugi Hospital

🇯🇵

Kanagawa, Japan

Centre de Recherche ADAPRA Inc.

🇨🇦

L'Ancienne-Lorette, Quebec, Canada

Recherche Clinique de Neurologie

🇨🇦

Montreal, Quebec, Canada

Nagoya City University Hospital

🇯🇵

Nagoya, Aichi,, Japan

National Hospital Organization Chiba-East Hospital

🇯🇵

Chiba, Japan

Nippon Medical School Chiba Hokusoh Hospital

🇯🇵

Chiba, Japan

Nishi-Kobe Medical Center

🇯🇵

Hyogo, Japan

Kobe City Hospital Org Kobe City Medical Cente West Hp

🇯🇵

Hyogo, Japan

Diex Research Sherbrooke Inc.

🇨🇦

Sherbrooke, Quebec, Canada

Gunma University Hospital

🇯🇵

Gunma, Japan

Iwate Medical University Hospital

🇯🇵

Iwate, Japan

University Hospital Center Zagreb

🇭🇷

Zagreb, Croatia

Szpital Uniwersytecki w Krakowie,Oddzial Kliniczny Klinik Chorób Wewnetrznych

🇵🇱

Krakow, Poland

Turku University Hospital

🇫🇮

Turku, Finland

Maebashi Red Cross Hospital

🇯🇵

Gunma, Japan

National Hospital Organization Niigata National Hospital

🇯🇵

Niigata, Japan

Juntendo Tokyo Koto Geriatric Medical Center

🇯🇵

Tokyo, Japan

Amphia Ziekenhuis

🇳🇱

Breda, Netherlands

National Hospital Organization Minami-Okayama Medical Center

🇯🇵

Okayama, Japan

Shonan Atsugi Hospital

🇯🇵

Kanagawa, Japan

Rakuwakai Otowa Hospital

🇯🇵

Kyoto, Japan

National HP.Org.Shizuoka Inst.Epilepsy,Neurological Disorder

🇯🇵

Shizuoka, Japan

National Hospital Organization Minami-Kyoto Hospital

🇯🇵

Kyoto, Japan

National Hospital Organization Maizuru Medical Center

🇯🇵

Kyoto, Japan

National Hospital Organization Matsumoto Medical Center

🇯🇵

Nagano, Japan

Osaka City University Hospital

🇯🇵

Osaka, Japan

Tokyo Medical University Hospital

🇯🇵

Tokyo, Japan

Tokyo Medical University Hachioji Medical Center

🇯🇵

Tokyo, Japan

Kansai Medical University Takii Hospital

🇯🇵

Osaka, Japan

Juntendo University Hospital

🇯🇵

Tokyo, Japan

Jeroen Bosch Ziekenhuis

🇳🇱

s. Hertogenbosch, Netherlands

Oddzial Neurologiczny i Udarowy Szpital Wolski im. dr Anny Gostynskiej,

🇵🇱

Warszawa, Poland

Saint-Petersburg Psychoneurological Research Institute n.a. V.M.Bekhterev

🇷🇺

Saint-Petersburg, Russian Federation

1. Neurologicka klinika

🇸🇰

Bratislava, Slovakia

Univerzitna nemocnica Bratislava

🇸🇰

Bratislava, Slovakia

OCA Hospital

🇲🇽

Monterrey, Nuevo León, Mexico

National Hospital Organization Tokyo National Hospital

🇯🇵

Tokyo, Japan

Vrije Universiteit Medisch Centrum

🇳🇱

Amsterdam, Netherlands

Catharina Ziekenhuis

🇳🇱

Eindhoven, Netherlands

NZOZ "SYNAPSA", ul. Niska 5/1

🇵🇱

Kielce, Poland

Instituto Biomedico de Investigacion A.C

🇲🇽

Aguascalientes, Mexico

Medisch Centrum Leeuwarden

🇳🇱

Leeuwarden, Netherlands

NZOZ "NEURO-KARD" "ILKOWSKI I PARTNERZY" Spolka Partnerska Lekarzy

🇵🇱

Poznan, Poland

Hospital Fernando da Fonseca

🇵🇹

Amadora, Portugal

Clinical Centre Kragujevac

🇷🇸

Kragujevac, Serbia

Neurologicka klinika

🇸🇰

Martin, Slovakia

Neurologicke oddelenie FNsP Zilina

🇸🇰

Zilina, Slovakia

Hospital General Universitario de Elche

🇪🇸

Elche, Alicante, Spain

Samodzielny Publiczny Centralny Szpital Kliniczny, Katedra i Klinika

🇵🇱

Warszawa, Poland

Hospitais Da Universidade De Coimbra

🇵🇹

Coimbra, Portugal

Hospital Santa Maria

🇵🇹

Lisboa, Portugal

Psychiatricka nemocnica Michalovce, n.o.

🇸🇰

Michalovce, Slovakia

Hospital Universitario Son Espases

🇪🇸

Palma de Mallorca, Islas Baleares, Spain

Klinicki centar Vojvodine

🇷🇸

Novi Sad, Vojvodina, Serbia

Interregional clinicodiagnostic center

🇷🇺

Kazan, Russian Federation

Chair of nervous system diseases

🇷🇺

Saint-Petersburg, Russian Federation

Klinicki centar Srbije

🇷🇸

Beograd, Serbia

Psychiatricka ambulancia

🇸🇰

Bratislava, Slovakia

Vseobecna nemocnica Rimavska Sobota

🇸🇰

Rimavska Sobota, Slovakia

CHUV Lausanne

🇨🇭

Lausanne, VD, Switzerland

Hospital Mutua de Terrasa

🇪🇸

Terrassa, Barcelona, Spain

CLONUS

🇪🇸

Palma de Mallorca, Islas Baleares, Spain

Signet Research

🇳🇿

Christchurch, New Zealand

NZOZ Dom Suer Ryder, Pallmed Sp. z o.o.

🇵🇱

Bydgoszcz, Poland

Kennemer Gasthuis

🇳🇱

Haarlem, Netherlands

Saint Petersburg Psychoneurological Research Institute n.a. V.M.Bekhterev

🇷🇺

Saint-Petersburg, Russian Federation

Boston University

🇺🇸

Boston, Massachusetts, United States

The Ohio State University

🇺🇸

Columbus, Ohio, United States

Clinical Trials Research Services, LLC

🇺🇸

Pittsburgh, Pennsylvania, United States

Loma Linda University Medical Center

🇺🇸

Loma Linda, California, United States

Pharmacology Research Institute

🇺🇸

Newport Beach, California, United States

Margolin Brain Institute

🇺🇸

Fresno, California, United States

Associated Neurologists of Southern Connecticut, P.C.

🇺🇸

Fairfield, Connecticut, United States

Neurologic Consultants, P.A.

🇺🇸

Fort Lauderdale, Florida, United States

Alpine Clinical Research Center, Inc.

🇺🇸

Boulder, Colorado, United States

ATP Clinical Research, Incorporated

🇺🇸

Costa Mesa, California, United States

Senior Clinical Trials, Incorporated

🇺🇸

Laguna Hills, California, United States

Medical Research and Health Education Foundation, Incorporated

🇺🇸

Columbus, Georgia, United States

Drug Shipment/ Storage

🇺🇸

Wichitia, Kansas, United States

Bringham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

IDS Pharmacy

🇺🇸

Boston, Massachusetts, United States

Advanced Imaging

🇺🇸

Ocala, Florida, United States

Neurostudies.net

🇺🇸

Lawrenceville, Georgia, United States

Alexian Brothers Neurosciences Institute

🇺🇸

Elk Grove Village, Illinois, United States

Collaborative Neuroscience Network, Inc.

🇺🇸

Long Beach, California, United States

Infusion Care Pharmacey

🇺🇸

Laguna Hills, California, United States

Neurostudies Inc

🇺🇸

Port Charlotte, Florida, United States

NeuroTrials Research, Incorporated

🇺🇸

Atlanta, Georgia, United States

Dedicated Clinical Research

🇺🇸

Goodyear, Arizona, United States

MD Clinical

🇺🇸

Hallandale Beach, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

University of Rochester/Strong Memorial Hospital

🇺🇸

Rochester, New York, United States

Bradenton Research Center, Incorporated

🇺🇸

Bradenton, Florida, United States

Hospital of the University of Pennslyvania

🇺🇸

Philadelphia, Pennsylvania, United States

UPENN Clinical and Translational Research Center (CTRC)

🇺🇸

Philadelphia, Pennsylvania, United States

Red River Medical Recearch Center, LLC

🇺🇸

Oklahoma City, Oklahoma, United States

Methodist Center for Senior Health

🇺🇸

Peoria, Illinois, United States

Alexian Brothers Medical Center

🇺🇸

Elk Grove Village, Illinois, United States

South Bay Internal Medicine

🇺🇸

Sun City, Florida, United States

Advanced Neurology Specialists

🇺🇸

Great Falls, Montana, United States

Penn Memory Center

🇺🇸

Philadelphia, Pennsylvania, United States

Methodist Medical Center of Illinois

🇺🇸

Peoria, Illinois, United States

Palm Beach Neurological Center

🇺🇸

Palm Beach Gardens, Florida, United States

Columbus Diagnostic Center (MRI)

🇺🇸

Columbus, Georgia, United States

NeuroStudies.net

🇺🇸

Decatur, Georgia, United States

Radio Pharmacy

🇺🇸

Paducah, Kentucky, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Neurocare, Incorporated

🇺🇸

Newton, Massachusetts, United States

AD-CARE, University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

Methodist Diagnostic Center

🇺🇸

Peoria, Illinois, United States

Northeast Radiology

🇺🇸

Brewster, New York, United States

Neurological Care of Central New York

🇺🇸

Liverpool, New York, United States

Investigational New Drug Services, IDS Pharmacy

🇺🇸

Philadelphia, Pennsylvania, United States

Cemic University Hospital

🇦🇷

Buenos Aires, Argentina

Alzheimer's Memory Center

🇺🇸

Charlotte, North Carolina, United States

Carolina Neuropsychological Services, Inc.

🇺🇸

Raleigh, North Carolina, United States

Precise Research Centers

🇺🇸

Flowood, Mississippi, United States

Rhode Island Mood and Memory Research Institute

🇺🇸

East Providence, Rhode Island, United States

Butler Hospital

🇺🇸

Providence, Rhode Island, United States

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

The Ohio State University Hospitals Clinic

🇺🇸

Columbus, Ohio, United States

Neurology Clinic, PC

🇺🇸

Cordova, Tennessee, United States

The Compounding Pharmacy

🇺🇸

Hickory, North Carolina, United States

Abington Neurological Associates

🇺🇸

Willow Grove, Pennsylvania, United States

Royal Adelaide Hospital

🇦🇺

Adelaide SA, Australia

The Memory Clinic

🇳🇿

Auckland, NZ, New Zealand

ALPHA Recherche Clinique

🇨🇦

Quebec, Canada

Hornsby Kuringai Hospital

🇦🇺

Hornsby, New South Wales, Australia

Heidelberg Repatriation Hospital/ Medical and Cognitive Research Unit

🇦🇺

West Heidelberg, Victoria, Australia

Sestre milosrdnice Zagreb

🇭🇷

Zagreb, Croatia

Unita' Operativa Complessa di Neurologia

🇮🇹

Catania, Italy

Ospedale S. Raffaele

🇮🇹

Milano, Italy

Fondazione IRCCS- Istituto Neurologico Carlo Besta

🇮🇹

Milano, Italy

CHU Hopital Nord

🇫🇷

Amiens, France

Hôpital Roger Salengro

🇫🇷

Lille, France

Hopital Maisonneuve-Rosemont

🇨🇦

Montreal, Quebec, Canada

University of Virginia General Clinical Research Center

🇺🇸

Charlottesville, Virginia, United States

CHU de Dijon

🇫🇷

Dijon, France

Universita Politecnica delle Marche

🇮🇹

Ancona, Italy

Hopital Sainte Marguerite

🇫🇷

Marseille, France

Universita degli Studi di Firenze

🇮🇹

Firenze, Italy

CHU de Caen

🇫🇷

Caen, France

CHU Nord - Hôpital Guillaume et René Laënnec

🇫🇷

Nantes - Saint Herblain, France

Toronto Memory Program

🇨🇦

Toronto, Ontario, Canada

University of Viriginia Investigational Pharmacy

🇺🇸

Charlottesville, Virginia, United States

Az. St. Jan Ruddershove 35

🇧🇪

Brugge, Belgium

CHU Hôpital Gui de Chaulliac

🇫🇷

Montpellier, France

Groupe Hospitalier Pitie-Salpetriere

🇫🇷

Paris Cedex 13, France

CHU La Milétrie

🇫🇷

Poitiers, France

C.H.U de Reims

🇫🇷

Reims, France

CHU - Hopital Charles Nicolle

🇫🇷

Rouen, France

CeSI (Centro di Scienze dell'invecchiamento) -

🇮🇹

Chieti, Italy

Gosford Hospital

🇦🇺

Gosford, New South Wales, Australia

Klinik fur Psychiatrie und Psychotherapie

🇩🇪

Berlin, Germany

Ospedale S. Gerardo

🇮🇹

Monza, Italy

CHRU Hôtel Dieu

🇫🇷

Rennes, Cedex, France

CHU Purpan - Hôpital Casselardit

🇫🇷

Toulouse, France

Universitaet Regensburg

🇩🇪

Regensburg, Germany

Clinica Neurologica

🇮🇹

Roma, Italy

Azienda Ospedaliera Spedali Civili di Brescia

🇮🇹

Brescia, Italy

Azienda Ospedaliera S. Gerardo di Monza Università di Milano Bicocca

🇮🇹

Monza, Italy

Groupe Hospitalier Broca-La Rochefoucauld

🇫🇷

Paris, France

Hôpital Purpan

🇫🇷

Toulouse, France

Universita degli Studi di Siena

🇮🇹

Siena, Italy

Hôpital la Timone

🇫🇷

Marseille, France

Ortenau Klinikum

🇩🇪

Offenburg, Germany

Tokyo Metoropolitan Health and Med. Treatment Co. Ebara Hosp

🇯🇵

Ota-ku, Tokyo, Japan

Kashiwado Hospital

🇯🇵

Chiba, Japan

KonKuk University Hospital, Department of NeuroPsychiatry

🇰🇷

Seoul, Korea, Republic of

Unita' Operativa C - Riabilitazione Neurologica

🇮🇹

Roma, Italy

National Hospital Organization Kokura Medical Center

🇯🇵

Fukuoka, Japan

Clínica CIMA

🇪🇸

Barcelona, Spain

Seoul National University Bundang Hospital, Department of Psychiatry

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

St Augustine's Medical Centre 2

🇿🇦

Durban, Kwa Zulu Natal, South Africa

Kagawa University Hospital

🇯🇵

Kagawa, Japan

Yokohama City University Medical Center

🇯🇵

Kanagawa, Japan

Okayama University Hospital

🇯🇵

Okayama, Japan

Denmar Clinic

🇿🇦

Pretoria, Gauteng, South Africa

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Boithuso Caregivers

🇿🇦

Johannesburg, Gauteng, South Africa

Skanes Universitetssjukhus, Neuropsykiatriska

🇸🇪

Malmo, Sweden

Kings College Hospital

🇬🇧

London, United Kingdom

Hospital de Cruces

🇪🇸

Baracaldo, Spain

Hopitaux Universitaires de Geneve

🇨🇭

Thonex-Geneva, Switzerland

The clinic: Minnes- och geriatrikmottagningen

🇸🇪

Uppsala, Sweden

Llandough Hospital

🇬🇧

Penarth, United Kingdom

Hospital Virgen del Puerto

🇪🇸

Plasencia, Caceres, Spain

Fundació ACE Institut Catala de Neurociences Aplicades

🇪🇸

Barcelona, Spain

Royal Hallamshire Hospital

🇬🇧

Sheffield, United Kingdom

Northampton General Hospital NHS Trust

🇬🇧

Northampton, United Kingdom

Hospital Universitario Ramon y Cajal

🇪🇸

Madrid, Spain

PET center

🇸🇪

Uppsala, Sweden

Grenoside Grange Hospital

🇬🇧

Sheffield, United Kingdom

Hospital Universitario La Princesa

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

MRI Dept: ORKI

🇸🇪

Uppsala, Sweden

MAC UK Neuroscience, Ltd.

🇬🇧

Bradford, West Yorkshire, United Kingdom

Glasgow Memory Clinic

🇬🇧

Glasgow, United Kingdom

KU - Wichita

🇺🇸

Wichita, Kansas, United States

Hollywood Private Hospital

🇦🇺

Nedlands, Western Australia, Australia

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

Banner Alzheimer's Institute

🇺🇸

Phoenix, Arizona, United States

Jeffrey S. Gitt, DO, PC

🇺🇸

Phoenix, Arizona, United States

The Compounding Center (IP Mixing Only)

🇺🇸

Phoenix, Arizona, United States

Hope Research Institute

🇺🇸

Phoenix, Arizona, United States

Coordinated Clinical Research

🇺🇸

San Diego, California, United States

Sharp Infusion Therapy Center

🇺🇸

San Diego, California, United States

LabCorp

🇺🇸

San Diego, California, United States

Sharp Mesa Vista Hospital

🇺🇸

San Diego, California, United States

San Francisco Clinical Research Center

🇺🇸

San Francisco, California, United States

Innovative Clinical Trials

🇺🇸

San Antonio, Texas, United States

Integra Clinical Research, LLC

🇺🇸

San Antonio, Texas, United States

Vista Infusions

🇺🇸

San Antonio, Texas, United States

Inventive Infusion Solutions

🇺🇸

San Antonio, Texas, United States

University of Alabama-Birmingham

🇺🇸

Birmingham, Alabama, United States

Professional Corporation of Psychiatry

🇺🇸

Oklahoma City, Oklahoma, United States

Flourish Integrative Pharmacy

🇺🇸

Oklahoma City, Oklahoma, United States

The Mile High Research Center

🇺🇸

Denver, Colorado, United States

Providence Brain Institute

🇺🇸

Portland, Oregon, United States

Kingshill Research Centre

🇬🇧

Swindon, United Kingdom

Hospital del Mar

🇪🇸

Barcelona, Spain

Ohio State University Imaging at Martha Morehouse

🇺🇸

Columbus, Ohio, United States

Psychology Associates

🇺🇸

Mishawaka, Indiana, United States

Simpson's Pharmacy

🇺🇸

Pawtucket, Rhode Island, United States

Bruyere Continuing Care

🇨🇦

Ottawa, Ontario, Canada

Michigan State University

🇺🇸

Lansing, Michigan, United States

Hôpital Neurologique

🇫🇷

Bron, France

Hôpitaux Civils de Colmar

🇫🇷

Colmar, France

Hôpital Cimiez

🇫🇷

Nice, France

Faculty Physicians and Surgeons of Loma Linda University School of Medicine

🇺🇸

Loma Linda, California, United States

Sharp and Children's MRI Center, LLC

🇺🇸

San Diego, California, United States

Sharp Memorial Hospital

🇺🇸

San Diego, California, United States

Associated Neurologists, PC

🇺🇸

Danbury, Connecticut, United States

JEM Research Institute LLC

🇺🇸

Atlantis, Florida, United States

Premiere Research Institute

🇺🇸

West Palm Beach, Florida, United States

Dekalb Neurology Associates, LLC/NeuroStudies.net, LLC

🇺🇸

Decatur, Georgia, United States

Methodist Medical Center Research Department

🇺🇸

Peoria, Illinois, United States

Memorial Medical Center

🇺🇸

Springfield, Illinois, United States

Elkhart Clinic, LLC

🇺🇸

Elkhart, Indiana, United States

Four Rivers Clinical Research, Incorporated

🇺🇸

Paducah, Kentucky, United States

ActivMed Practices and Research, Inc.

🇺🇸

Haverhill, Massachusetts, United States

Springfield Neurology Associates, LLC

🇺🇸

Springfield, Massachusetts, United States

Comprehensive Clinical Research

🇺🇸

Berlin, New Jersey, United States

Hattiesburg Clinic

🇺🇸

Hattiesburg, Mississippi, United States

Alzheimer's Research Corporation

🇺🇸

Manchester, New Jersey, United States

Clinical Study Center of Asheville, LLC

🇺🇸

Asheville, North Carolina, United States

Raleigh Neurology Associates, PA

🇺🇸

Raleigh, North Carolina, United States

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Clinical Trial Center, LLC

🇺🇸

Jenkintown, Pennsylvania, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Radiant Research, Incorporated

🇺🇸

Greer, South Carolina, United States

Medical University of South Carolina

🇺🇸

North Charleston, South Carolina, United States

Texas Neurology, P.A.

🇺🇸

Dallas, Texas, United States

Southwestern Vermont Healthcare

🇺🇸

Bennington, Vermont, United States

CDAMS Ballarat Base Hospital

🇦🇺

Ballarat, Victoria, Australia

Hospital Italiano de Buenos Aires

🇦🇷

Buenos Aires, Argentina

The Queen Elizabeth Hospital

🇦🇺

Woodville South, South Australia, Australia

ZNA Middelheim / Neurologie

🇧🇪

Antwerpen, Belgium

McCusker Alzheimer's Research Foundation Inc.

🇦🇺

Nedlands, Western Australia, Australia

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

University Hospital Gathuisberg

🇧🇪

Leuven, Belgium

H.-Hartziekenhuis Roeselare-Menen

🇧🇪

Roeselare, Belgium

Medical Specialists of the Palm Beaches

🇺🇸

Atlantis, Florida, United States

North Broward Medical Center

🇺🇸

Deerfield Beach, Florida, United States

Southern Illinois University School of Medicine

🇺🇸

Springfield, Illinois, United States

Neurology & Neuroscience Center of Ohio

🇺🇸

Toledo, Ohio, United States

Brain Matters Research

🇺🇸

Delray Beach, Florida, United States

General Clinical Research Center

🇺🇸

Boston, Massachusetts, United States

Clinical Trials of America, Incorporated

🇺🇸

Hickory, North Carolina, United States

Roskamp Institute

🇺🇸

Sarasota, Florida, United States

Healthsouth Blue Ridge Surgery Center

🇺🇸

Raleigh, North Carolina, United States

Wake Radiology Associates

🇺🇸

Raleigh, North Carolina, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Pacific Medical Centers

🇺🇸

Seattle, Washington, United States

University of North Texas Health Science Center

🇺🇸

Fort Worth, Texas, United States

Grayline Clinical Drug Trials

🇺🇸

Wichita Falls, Texas, United States

University of Virginia Neurology

🇺🇸

Charlottesville, Virginia, United States

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

St. Josef-Klinikum

🇩🇪

Bochum, Germany

Hospital Universitario Virgen de la Arrixaca

🇪🇸

Murcia, Spain

Hospital of the University of Pennsylvania (PET)

🇺🇸

Philadelphia, Pennsylvania, United States

Kobe University Hospital

🇯🇵

Hyogo, Japan

Osaka University Hospital

🇯🇵

Osaka, Japan

Nizhny Novgorod regional clinical hospital n.a. N.A.Semashko

🇷🇺

Nizhny Novgorod, Russian Federation

Saint-Petersburg State institution of healthcare, City geriatric medico-social center

🇷🇺

Saint-Petersburg, Russian Federation

The Osteoporosis and Memory Centre

🇿🇦

Johannesburg, Gauteng, South Africa

Panorama Psychiatry and Memory Clinic

🇿🇦

Panorama, Western Cape, South Africa

Hospital Divino Valles

🇪🇸

Burgos, Spain

Hospital Clinico San Carlos

🇪🇸

Madrid, Spain

Memory Clinic Neuro-Psychologie Zentrum

🇨🇭

Basel, BS, Switzerland

Newcastle General Hospital

🇬🇧

Newcastle upon Tyne, United Kingdom

Clinical Investigation and Research Unit (CIRU)

🇬🇧

Brighton, United Kingdom

MAC UK Neuroscience Ltd

🇬🇧

Blackpool, Lancashire, United Kingdom

Dept. of Neurosciences Charing Cross Hospital

🇬🇧

London, United Kingdom

Compass Research, LLC

🇺🇸

Orlando, Florida, United States

Foers Medical Arts Pharmacy

🇺🇸

Bethesda, Maryland, United States

Institute for Neurodegenerative Disorders

🇺🇸

New Haven, Connecticut, United States

Yale University School of Medicine

🇺🇸

New Haven, Connecticut, United States

Institutional Review Board / Ethics Committee

🇺🇸

New Haven, Connecticut, United States

Yale PET Center

🇺🇸

New Haven, Connecticut, United States

Stedman Clinical Trials, LLC

🇺🇸

Tampa, Florida, United States

University of Michigan Health System

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan Hospital

🇺🇸

Ann Arbor, Michigan, United States

Yale-New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Norman S. Werdiger, MD

🇺🇸

New Haven, Connecticut, United States

The Center for Pharmaceutical Research

🇺🇸

Kansas City, Missouri, United States

Medical University of South Carolina Hospitals and Clinics

🇺🇸

Charleston, South Carolina, United States

Medical University of South Carolina Investigational Drug Service

🇺🇸

Charleston, South Carolina, United States

Louisiana Research Associates Inc

🇺🇸

New Orleans, Louisiana, United States

Austin Infusion Centers

🇺🇸

Austin, Texas, United States

Senior Adults Specialty Research

🇺🇸

Austin, Texas, United States

Centre for Memory and Aging

🇨🇦

North York, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath